NO20074780L - Heterocyklylamidsubstituerte imidazoler - Google Patents

Heterocyklylamidsubstituerte imidazoler

Info

Publication number
NO20074780L
NO20074780L NO20074780A NO20074780A NO20074780L NO 20074780 L NO20074780 L NO 20074780L NO 20074780 A NO20074780 A NO 20074780A NO 20074780 A NO20074780 A NO 20074780A NO 20074780 L NO20074780 L NO 20074780L
Authority
NO
Norway
Prior art keywords
heterocyclylamide
substituted imidazoles
prophylaxis
diseases
preparation
Prior art date
Application number
NO20074780A
Other languages
English (en)
Other versions
NO338997B1 (no
Inventor
Armin Kern
Martin Radtke
Martin Hendrix
Ulrich Rosentreter
Dieter Lang
Holger Zimmermann
David Brueckner
Keistin Henninger
Joerg Keldenich
Daniela Paulsen
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36675125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074780(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of NO20074780L publication Critical patent/NO20074780L/no
Publication of NO338997B1 publication Critical patent/NO338997B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår heterosyklylamidsubstituerte imidazoler og fremgangsmåter for fremstilling av samme, anvendelse derav for behandling og/eller profylakse av sykdommer, anvendelse derav for fremstilling av medikamenter for behandling og/eller profylakse av sykdommer, og særlig anvendelse derav som antivirale midler, særlig overfor cytomegaloviruser.
NO20074780A 2005-02-23 2007-09-19 Heterocyklylamidsubstituerte imidazoler NO338997B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005008183A DE102005008183A1 (de) 2005-02-23 2005-02-23 Heterocyclylamid-substituierte Imidazole
PCT/EP2006/001325 WO2006089664A2 (de) 2005-02-23 2006-02-14 Heterocyclylamid-substituierte imidazole

Publications (2)

Publication Number Publication Date
NO20074780L true NO20074780L (no) 2007-11-01
NO338997B1 NO338997B1 (no) 2016-11-07

Family

ID=36675125

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074780A NO338997B1 (no) 2005-02-23 2007-09-19 Heterocyklylamidsubstituerte imidazoler

Country Status (28)

Country Link
US (1) US7919489B2 (no)
EP (1) EP1853582B1 (no)
JP (1) JP5208522B2 (no)
KR (1) KR101276003B1 (no)
CN (1) CN101128455B (no)
AR (1) AR053141A1 (no)
AT (1) ATE446292T1 (no)
AU (1) AU2006218276C1 (no)
BR (1) BRPI0607995B8 (no)
CA (1) CA2598521C (no)
DE (2) DE102005008183A1 (no)
DK (1) DK1853582T3 (no)
ES (1) ES2333249T3 (no)
GT (1) GT200600077A (no)
HN (2) HN2006007774A (no)
IL (1) IL185050A (no)
MX (1) MX2007010308A (no)
MY (1) MY140543A (no)
NO (1) NO338997B1 (no)
NZ (1) NZ560811A (no)
PE (2) PE20100233A1 (no)
PL (1) PL1853582T3 (no)
PT (1) PT1853582E (no)
RU (1) RU2415851C2 (no)
TW (1) TWI388553B (no)
UY (1) UY29387A1 (no)
WO (1) WO2006089664A2 (no)
ZA (1) ZA200707412B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
CN104610160A (zh) * 2013-11-04 2015-05-13 南京大学 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用
CN104016925B (zh) * 2014-06-17 2016-03-30 遵义医学院 4-烷基咪唑-2-羧酸的合成方法
KR20180028456A (ko) 2015-06-22 2018-03-16 다이닛본 스미토모 세이야꾸 가부시끼가이샤 1,4-디치환 이미다졸 유도체
JP6507976B2 (ja) * 2015-09-30 2019-05-08 東レ株式会社 イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法
CN116120238B (zh) * 2023-03-01 2023-09-22 山东梅奥华卫科技有限公司 一种咪唑衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342501B1 (en) 1994-02-25 2002-01-29 The Regents Of The University Of Michigan Pyrrolo[2,3-d] pyrimidines as antiviral agents
DE69826695T2 (de) * 1997-05-23 2006-02-02 Bayer Pharmaceuticals Corp., West Haven Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
EP1028953A1 (en) 1997-11-03 2000-08-23 Boehringer Ingelheim Pharmaceuticals Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
CN1291979C (zh) * 1998-07-23 2006-12-27 安斯泰来制药有限公司 咪唑化合物及其作为腺苷脱氨酶抑制剂的用途
EP1144399A3 (en) 1998-12-09 2002-09-11 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
DE10257358A1 (de) 2002-12-09 2004-07-08 Bayer Healthcare Ag Substituierte Pyrrole
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
MXPA06013118A (es) * 2004-05-12 2007-02-28 Schering Corp Antagonistas de cxcr1 y cxcr2 de quimocina.
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole

Also Published As

Publication number Publication date
HN2010000128A (es) 2010-03-29
AU2006218276B2 (en) 2011-04-07
EP1853582A2 (de) 2007-11-14
GT200600077A (es) 2006-10-03
US20080176859A1 (en) 2008-07-24
MX2007010308A (es) 2007-10-17
AU2006218276A1 (en) 2006-08-31
PE20061141A1 (es) 2006-12-29
BRPI0607995B1 (pt) 2019-07-16
JP5208522B2 (ja) 2013-06-12
PT1853582E (pt) 2009-11-13
EP1853582B1 (de) 2009-10-21
NZ560811A (en) 2010-07-30
DK1853582T3 (da) 2010-01-18
NO338997B1 (no) 2016-11-07
PL1853582T3 (pl) 2010-03-31
MY140543A (en) 2009-12-31
IL185050A0 (en) 2007-12-03
TW200700411A (en) 2007-01-01
RU2415851C2 (ru) 2011-04-10
CN101128455B (zh) 2013-01-16
BRPI0607995B8 (pt) 2021-05-25
KR101276003B1 (ko) 2013-06-20
TWI388553B (zh) 2013-03-11
RU2007135277A (ru) 2009-03-27
CA2598521C (en) 2012-11-27
PE20100233A1 (es) 2010-04-22
HK1110857A1 (zh) 2008-07-25
CA2598521A1 (en) 2006-08-31
KR20080002772A (ko) 2008-01-04
DE102005008183A1 (de) 2006-08-31
IL185050A (en) 2013-01-31
ATE446292T1 (de) 2009-11-15
WO2006089664A3 (de) 2006-11-02
HN2006007774A (es) 2010-03-29
WO2006089664A2 (de) 2006-08-31
DE502006005182D1 (de) 2009-12-03
ZA200707412B (en) 2008-12-31
CN101128455A (zh) 2008-02-20
UY29387A1 (es) 2006-10-02
ES2333249T3 (es) 2010-02-18
US7919489B2 (en) 2011-04-05
JP2008531508A (ja) 2008-08-14
AU2006218276C1 (en) 2012-06-28
BRPI0607995A2 (pt) 2009-10-27
AR053141A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
NO20064584L (no) Tetrahydropyridoindolderivater
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
TW200510343A (en) Substituted dihydroquinazolines
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
UA106367C2 (uk) Похідні азадиспіро[3.0.4.1]декану та їх застосування
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
ATE453642T1 (de) Substituierte phenylaminopyrimidine
ATE448232T1 (de) Substituierte heterozyklen
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
MY150931A (en) Substituted oxazolidinones and their use
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
ATE380188T1 (de) Substituierte chinolone
ATE524488T1 (de) Lysobactinamide
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
MY151590A (en) Substituted quinolones iii
UY31131A1 (es) "oxazolidinonas sustituidas y su uso
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees